News Release #12-015 October 8, 2012

FOR IMMEDIATE RELEASE Contact: Krista A. Kittle (315) 785-4504

SMC PAIN MANAGEMENT CENTER DOES NOT CARRY RECALLED DRUG Patients Being Reassured SMC Drug Supply is Safe
Watertown, New York ----- Samaritan Medical Center’s Pain Management Center has been receiving numerous calls from patients concerned about a national recall on a drug that has been linked to an outbreak of fungal meningitis. Physicians and staff at the Pain Management Center are reassuring patients that SMC’s supply of the drug, methylprednisolone acetate, is safe and was not provided by the company at the focus of the recall. “Our supply of methylprednisolone acetate is ordered directly from the manufacturer and not from the compounding pharmacy in question, New England Compounding Center,” explains Joseph Sanzone, RPh, Director of Pharmacy at SMC. “We want to reassure our patients that our supply of this drug is safe and not among the lots of medication that have been recalled, and not even from the same supplier.” Since national reports of the fungal meningitis outbreak, the FDA investigated the New England Compounding Center, which has since shut down its operations. “Patient safety is our number one priority here at Samaritan,” Bhupinder Bolla, MD, one of SMC’s fellowship-trained pain management physicians. “Our team here at the Pain Center and throughout the hospital takes any and all steps necessary to prevent infection or exposure to contaminated materials. Our patients can rest assured that our supply of methylprednisolone acetate is safe and continues to be an extremely successful intervention to relieve chronic pain and return patients to their active lives.”

###